blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3508220

EP3508220 - PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  28.01.2022
Database last updated on 23.04.2024
FormerRequest for examination was made
Status updated on  07.06.2019
Most recent event   Tooltip22.08.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
GlaxoSmithKline Biologicals S.A.
Rue de l'Institut, 89
1330 Rixensart / BE
[2019/28]
Inventor(s)01 / GEALL, Andrew
Novartis Vaccines and Diagnostics, Inc
IP Services M/s X-100b
4560 Horton Street
Emeryville, CA 94608-2916 / US
02 / VERMA, Ayush
Novartis Vaccines and Diagnostics, Inc
IP Services M/s X-100b
4560 Horton Street
Emeryville, CA 94608-2916 / US
 [2019/28]
Representative(s)Hitchcock, Lucy Rose
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2019/28]Sanderson, Andrew John, et al
GlaxoSmithKline
Global Patents, CN9.25.1
980 Great West Road
Brentford
Middlesex TW8 9GS / GB
Application number, filing date18201799.631.08.2012
[2019/28]
Priority number, dateUS201161529878P31.08.2011         Original published format: US 201161529878 P
[2019/28]
Previously filed application, dateWO2012US5339131.08.2012
[2019/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3508220
Date:10.07.2019
Language:EN
[2019/28]
Search report(s)(Supplementary) European search report - dispatched on:EP31.05.2019
ClassificationIPC:A61K39/39, A61K9/127, A61K9/00
[2019/28]
CPC:
A61K9/0019 (EP,RU,US); A61K9/127 (RU,US); A61K31/713 (EP,RU,US);
A61K39/12 (EP,RU,US); A61K9/1271 (EP,RU,US); A61P31/14 (EP,US);
C12N15/88 (EP,RU,US); A61K2039/53 (EP,RU,US); A61K2039/55505 (EP,RU,US);
A61K2039/55555 (EP,RU,US); A61K2039/57 (EP,RU,US); A61K39/155 (EP,RU,US);
A61K39/245 (EP,RU,US); C12N2710/16134 (EP,RU,US); C12N2760/18534 (EP,RU,US);
C12N2770/36143 (EP,RU,US); Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/28]
TitleGerman:PEGYLIERTE LIPOSOME ZUR FREISETZUNG VON IMMUNOGEN-CODIERENDER RNA[2019/28]
English:PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA[2019/28]
French:LIPOSOMES PÉGYLÉS POUR L'ADMINISTRATION D'ARN CODANT UN IMMUNOGÈNE[2019/28]
Examination procedure22.10.2018Examination requested  [2019/28]
08.01.2020Amendment by applicant (claims and/or description)
01.02.2022Despatch of a communication from the examining division (Time limit: M04)
25.02.2022Despatch of a communication from the examining division (Time limit: M06)
28.09.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
24.11.2022Reply to a communication from the examining division
Parent application(s)   TooltipEP12769787.8  / EP2750707
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
24.11.2022Request for further processing filed
24.11.2022Full payment received (date of receipt of payment)
Request granted
09.01.2023Decision despatched
Fees paidRenewal fee
22.10.2018Renewal fee patent year 03
22.10.2018Renewal fee patent year 04
22.10.2018Renewal fee patent year 05
22.10.2018Renewal fee patent year 06
22.10.2018Renewal fee patent year 07
08.08.2019Renewal fee patent year 08
17.08.2020Renewal fee patent year 09
18.08.2021Renewal fee patent year 10
19.08.2022Renewal fee patent year 11
22.08.2023Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP1083232  (JUNG GUENTHER PROF DR [DE], et al) [A] 1-12 * abstract *;
 [Y]WO2010088537  (ALNYLAM PHARMACEUTICALS INC [US], et al) [Y] 1-12 * page 1 * * page 7; claims 28-30 * * page 11, paragraph l * * page 88, paragraph l - page 89, paragraph 1 *;
 [Y]WO2011008974  (NOVARTIS AG [CH], et al) [Y] 1-12 * pages 55-56; example 7 *;
 [XP]WO2012006376  (NOVARTIS AG [CH], et al) [XP] 1-12 * page 3, paragraph 3 * * page 20, lines 13-14; example 1 *;
 [XP]WO2012030901  (NOVARTIS AG [CH], et al) [XP] 1-12 * page 31, paragraph l * * page 33, paragraph 3 ** page 40, line 10 *;
 [X]  - MARYAM AMIDI ET AL, "Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine", SYSTEMS AND SYNTHETIC BIOLOGY, SPRINGER NETHERLANDS, DORDRECHT, (20101026), vol. 5, no. 1 - 2, doi:10.1007/S11693-010-9066-Z, ISSN 1872-5333, pages 21 - 31, XP019943076 [X] 1,5,10-12 * pages 22-23 * * page 23, column l, paragraph l - page 23, column r, paragraph 1 *

DOI:   http://dx.doi.org/10.1007/s11693-010-9066-z
 [X]  - HIROSHI KITA ET AL, "Replication of Genetic Information with Self-Encoded Replicase in Liposomes", CHEMBIOCHEM, (20081013), vol. 9, no. 15, doi:10.1002/cbic.200800360, ISSN 1439-4227, pages 2403 - 2410, XP055007329 [X] 1,5-7 * page 2406, column r, paragraph l * * page 2409, column l, paragraph 2 * * page 2409, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1002/cbic.200800360
 [Y]  - KLIBANOV A L ET AL, "Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 268, no. 1, doi:10.1016/0014-5793(90)81016-H, ISSN 0014-5793, (19900730), pages 235 - 237, (19900730), XP025890437 [Y] 1-12 * page 236, column l, paragraph l - page 236, column r, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/0014-5793(90)81016-H
 [Y]  - ABDERRAHIM AISSAOUI ET AL, "Efficient topical delivery of plasmid DNA to lung in vivo mediated by putative triggered, PEGylated pDNA nanoparticles", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 154, no. 3, doi:10.1016/J.JCONREL.2011.06.017, ISSN 0168-3659, (20110604), pages 275 - 284, (20110615), XP028285878 [Y] 1-12 * abstract *

DOI:   http://dx.doi.org/10.1016/j.jconrel.2011.06.017
 [XP]  - MARYAM AMIDI ET AL, "Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes", JOURNAL OF CONTROLLED RELEASE, (20120801), doi:10.1016/j.jconrel.2012.08.016, ISSN 0168-3659, XP055044026 [XP] 1,5,10-12 * page 3, column l * * page 20, lines 13-14 * * example 1 *

DOI:   http://dx.doi.org/10.1016/j.jconrel.2012.08.016
by applicantWO0202606
 WO0234771
 WO03018054
 WO2005002619
 WO2005032582
 WO2005111066
 WO2005113782
 WO2005121348
 WO2006089264
 WO2006091517
 WO2006110413
 WO2006138004
 WO2007049155
 WO2008020330
 WO2009016515
 WO2009031043
 WO2009104092
 WO2009109860
 WO2010119343
 WO2011005799
 WO2011057020
 WO2011076807
    - D. HELLWINKEL, Systemic Nomenclature of Organic Chemistry, Springer, (20010000), page 203
    - JOHANNING et al., Nucleic Acids Res, (19950000), vol. 23, pages 1495 - 1501
    - HEYES et al., J Controlled Release, (20050000), vol. 107, pages 276 - 87
    - Liposome Technology, Informa Healthcare, (20060000), vol. I, II, I
    - Functional Polymer Colloids and Microparticles volume 4 (Microspheres, microcapsules & liposomes), Citus Books, (20020000), vol. 4
    - JEFFS et al., Pharmaceutical Research, (20050000), vol. 22, no. 3, pages 362 - 372
    - EL OUAHABI et al., FEBS Letts, (19960000), vol. 380, pages 108 - 12
    - GIULIANI et al., Proc Natl Acad Sci USA, (20060000), vol. 103, no. 29, pages 10834 - 9
    - GENNARO, Remington: The Science and Practice of Pharmacy, (20000000), ISBN 0683306472
    - ROMBERG et al., Pharmaceutical Research, (20080000), vol. 25, pages 55 - 71
    - HOEKSTRA et al., Biochimica et Biophysica Acta, (20040000), vol. 1660, pages 41 - 52
    - Methods In Enzymology, Academic Press, Inc.
    - Handbook of Experimental Immunology, Blackwell Scientific Publications, (19860000), vol. I, IV
    - YONEYAMA; FUJITA, Cytokine & Growth Factor Reviews, (20070000), vol. 18, pages 545 - 51
    - MAURER et al., Biophysical Journal, (20010000), vol. 80, pages 2310 - 2326
    - PERRI et al., J Virol, (20030000), vol. 77, pages 10394 - 10403
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.